openPR Logo
Press release

Genitourinary Drugs Market Record an Exponential CAGR by 2024

08-21-2017 12:19 PM CET | Health & Medicine

Press release from: Persistence Market Research

Genitourinary Drugs Market Record an Exponential CAGR by 2024

Genitourinary cancers are cancer in the urinary system e.g. prostate cancer, ovarian cancer, bladder cancer and cervical cancer. Growing incidence of genitourinary disorder will drive genitourinary drug market. Many pipeline drugs are under development that will expand the scope in the next few years.

A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/12706


Increased demand of generics, continual patent expiration and the presence of counterfeit drugs is expected to impede the global genitourinary drug market. Earlier, patients suffering from the genitourinary system were provided with steroids and immunosuppressant, but it caused serious side effects such as diarrhea, nausea, and vomiting. To overcome side effects biological drugs turned up that may cause fever only and are highly efficient in the treatment of genitourinary infections.

To view TOC of this report is available upon request @ http://www.persistencemarketresearch.com/toc/12706

As of January 2014, about 3 million men had a history of prostate cancer, 608,620 had urinary bladder cancer, and 244,110 testicular cancer survivors were in the US. It is estimated that by 2024, the population of cancer survivors will increase almost 19 million. Technological advancement in genitourinary devices and rising concern about urinary health is anticipated to accelerate the growth of global genitourinary drug market.

Buy Now: You can now buy a single user license of the report @ http://www.persistencemarketresearch.com/checkout/12706

The global genitourinary drug market is segmented, by indication and product type. Based on the indication the global genitourinary drugs market is segmented into genitourinary cancer, kidney/renal cancer, ovarian cancer, bladder cancer, cervical cancer, prostate cancer, erectile dysfunction, urinary tract infections, sexually transmitted diseases, interstitial cystitis and others. Prostate cancer share is high in the indication segment.

About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Genitourinary Drugs Market Record an Exponential CAGR by 2024 here

News-ID: 676894 • Views:

More Releases from Persistence Market Research

Global Automotive Active Health Monitoring Systems Market Expected to Surge from US$ 683.9 Mn in 2025 to US$ 2,338.3 Mn by 2032 at 19.2% CAGR | Persistence Market Research
Global Automotive Active Health Monitoring Systems Market Expected to Surge from …
The Automotive Active Health Monitoring Systems Market is poised for significant growth over the forecast period of 2025 to 2032. This market is projected to expand from USD 683.9 million in 2025 to USD 2,338.3 million by 2032, registering a robust CAGR of 19.20%. Automotive active health monitoring systems are designed to track the real-time status of vehicles, enabling predictive maintenance, reducing downtime, and enhancing overall vehicle safety. With growing
Primary Packaging Labels Market to Reach US$12.2 Bn by 2031 with Steady Growth at 3.3% CAGR - Persistence Market Research
Primary Packaging Labels Market to Reach US$12.2 Bn by 2031 with Steady Growth a …
➤Overview of the Market The global primary packaging labels market is a crucial segment of the packaging industry, enabling product identification, regulatory compliance, and brand differentiation. Primary labels are applied directly on product packaging, such as bottles, vials, boxes, and pouches, serving both functional and promotional roles. As consumer awareness of product authenticity and safety continues to rise, demand for innovative labeling solutions is expanding. Moreover, stringent regulatory frameworks in industries
Shelf Stable Packaging Market to Reach US$10.7 Bn by 2031 with Steady Growth at 2.4% CAGR - Persistence Market Research
Shelf Stable Packaging Market to Reach US$10.7 Bn by 2031 with Steady Growth at …
➤Overview of the Market The shelf stable packaging market plays a critical role in extending the shelf life of food and beverages without the need for refrigeration, ensuring product safety, convenience, and affordability. These packaging solutions-spanning cartons, pouches, cans, and plastic containers-are widely used in ready-to-eat meals, dairy alternatives, sauces, soups, and beverages. Growth in the market is closely linked to evolving consumer lifestyles, increasing urbanization, and demand for long-lasting packaged
Print Label Market to Reach US$68.6 Bn by 2031 with Steady Growth at 4.3% CAGR - Persistence Market Research
Print Label Market to Reach US$68.6 Bn by 2031 with Steady Growth at 4.3% CAGR - …
➤Overview of the Market The global print label market is poised for substantial expansion, driven by increasing demand across industries such as food & beverages, pharmaceuticals, cosmetics, and logistics. Labels play a crucial role in brand identity, product differentiation, and regulatory compliance. In addition to providing essential information like product ingredients, expiration dates, and barcodes, printed labels serve as key marketing tools that influence consumer purchase decisions. With the rapid rise

All 5 Releases


More Releases for Genitourinary

Global Genitourinary Robotic Surgery Market | Key Players are Segmentation of Ge …
The Global Genitourinary Robotic Surgery Market is estimated to exhibit a CAGR of 12.3% during the forecast period. Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1339 Robotic surgery is a minimally invasive surgery that employs robotic technology to carry out surgical procedures. These automated devices are controlled by surgeons and feature miniature surgical tools that are attached to robotic arms, enabling surgeons to perform surgery precisely. Laparoscopic or minimally invasive
Genitourinary Robotic Surgery Market Size - Forecast to 2026
As per the research conducted by GME, the Global Genitourinary Robotic Surgery Market is projected to grow at a CAGR value of 11.5% during the forecast period of 2021 to 2026. Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Global Genitourinary Robotic Surgery Market - Forecast to 2026" https://www.globalmarketestimates.com/market-report/genitourinary-robotic-surgery-market-3318 By Product Type (Robotic Surgery Instrument, Accessories, and Services), By Component (Robotic Surgery Machine,
Genitourinary Drugs Market to Witness Exponential Growth by 2024
Genitourinary drugs are used to treat disorders affecting the kidneys, bladder, ureters, and urethra. Since long, patients suffering from disorders and infections related to genitourinary systems have been depending on steroids and immunosuppressants which are chemically synthesized and may reciprocate with some serious side effects such as insomnia, acne, nausea, vomiting, and diarrhea. As a result, patients are now turning to biological drugs that not only cause fewer to no
Global Genitourinary Drugs Market:Potential Segments & their Contribution to Mar …
LOS ANGELES, United States: QY Research as of late produced a research report titled, “Global Genitourinary Drugs Market Research Report 2020". The research report speak about the potential development openings that exist in the worldwide market. The report is broken down on the basis of research procedures procured from historical and forecast information. The global Genitourinary Drugs market is relied upon to develop generously and flourish as far as volume
Global and Chinese Genitourinary Drugs Industry, 2018 Market Research Report
Global Genitourinary Drugs Market provides a basic overview of the markets including definitions, classifications, applications and industry chain structure. The Genitourinary Drugs Market analysis is provided for the international Industry including development trends, competitive landscape analysis, and key regions development status. The Genitourinary Drugs report provides key statistics on the market status of the Genitourinary Drugs Market manufacturers and is a valuable source of guidance and direction for companies and
United States Genitourinary Drugs Market: By Applications - Genitourinary Cancer …
Latest industry research report on: United States Genitourinary Drugs Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Download Sample copy of this Report at :http://www.marketresearchreports.biz/sample/sample/972418 This report studies sales (consumption) of Genitourinary Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering Astellas Pfizer GlaxoSmithKline